Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA2)
Clinical trial NCT04797650 · COMPLETED
Trial details
- NCT number
- NCT04797650
- Sponsor
- Concert Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-10
- Primary completion
- 2022-06-08
- Enrollment
- 517
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.